Surgery for Gastrointestinal Metastases of Malignant Melanoma - a Single Center Retrospective Cohort Study
SurgMelMet
1 other identifier
observational
15
1 country
1
Brief Summary
The aim is to conduct a single centre retrospective study of all patients with stage IV melanoma that underwent surgery for metastases at Sahlgrenska University Hospital between 2010-01-01 and 2018-12-31. Pre- and postoperative data will be collected from digital medical records, the Swedish Cancer Registry, the Swedish Cause of Death Register as well as from the national Swedish cancer patient database (INCA). If needed, patient records will be collected from other hospitals. Results will be presented in written format as a summary and analysis of the characteristics of the cases operated on during the inclusion period. The aim is to identify predictive and prognostic factors for outcome and complications in the surgical treatment of stage IV metastatic melanoma.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for all trials
Started Jan 2010
Longer than P75 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
January 1, 2010
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 31, 2018
CompletedStudy Completion
Last participant's last visit for all outcomes
December 31, 2018
CompletedFirst Submitted
Initial submission to the registry
March 15, 2019
CompletedFirst Posted
Study publicly available on registry
March 18, 2019
CompletedJanuary 26, 2024
January 1, 2024
9 years
March 15, 2019
January 25, 2024
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Overall survival
Overall survival
December 2018
Secondary Outcomes (1)
Complications according to Clavien-Dindo within 90 days.
90 days
Study Arms (1)
Cohort
Patients with stage IV malignant melanoma with abdominal metastasis (M1c) that underwent abdominal surgery with metastasectomy during the study period.
Interventions
Emergency or elective surgery on indications related to abdominally metastasized malignant melanoma
Eligibility Criteria
Patients with abdominally metastasized malignant melanoma stage IV.
You may qualify if:
- Biopsy verified stage IV malignant melanoma, stage M1c.
- Having undergone surgery with metastasectomy of melanoma tumors.
You may not qualify if:
- retroperitoneal tumors
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Sahlgrenska University Hospital
Gothenburg, 413 45, Sweden
Related Publications (1)
Holmberg CJ, Alwan G, Ny L, Olofsson Bagge R, Katsarelias D. Surgery for gastrointestinal metastases of malignant melanoma - a retrospective exploratory study. World J Surg Oncol. 2019 Jul 12;17(1):123. doi: 10.1186/s12957-019-1663-z.
PMID: 31299988DERIVED
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- RETROSPECTIVE
- Sponsor Type
- OTHER GOV
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Associate Professor, Senior Consultant Surgeon
Study Record Dates
First Submitted
March 15, 2019
First Posted
March 18, 2019
Study Start
January 1, 2010
Primary Completion
December 31, 2018
Study Completion
December 31, 2018
Last Updated
January 26, 2024
Record last verified: 2024-01